证券记录 · 已归档季度
CRL
Charles River Laboratories International, Inc. · Healthcare · Medical - Diagnostics & Research
14被追踪持有人
n/aΔ持有人
3.92M持有股份
$810.09M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 138 | -1 | 45.11M | $10.22B | +6 | −8 |
| Q1 2026 | 143 | -7 | 45.52M | $7.86B | +6 | −14 |
| Q4 2025 | 150 | +3 | 43.69M | $8.72B | +4 | n/a |
| Q3 2025 | 22 | 0 | 23.18M | $3.62B | +1 | −2 |
| Q2 2025 | 20 | +2 | 21.36M | $3.24B | +4 | −2 |
| Q1 2025 | 15 | 0 | 9.57M | $1.44B | +1 | −1 |
| Q4 2024 | 15 | +1 | 9.65M | $1.78B | +1 | n/a |
| Q3 2024 | 13 | -1 | 6.67M | $1.31B | n/a | −1 |
| Q2 2024 | 14 | n/a | 3.92M | $810.09M | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 1.22M | n/a | $250.70M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Marshall Wace ✦ | 825.90K | n/a | $170.62M | 0.2% | n/c | 1 | SEC ↗ ×3 |
| 3 | T. Rowe Price ✦ | 640.99K | n/a | $132.42M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 514.24K | n/a | $106.23M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | PRIMECAP Management ✦ | 273.73K | n/a | $56.55M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 183.11K | n/a | $37.83M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Baillie Gifford ✦ | 67.54K | n/a | $13.95M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | AQR Capital Management ✦ | 62.25K | n/a | $12.86M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | Gotham Asset Management ✦ | 51.12K | n/a | $10.56M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 42.27K | n/a | $8.73M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 28.86K | n/a | $5.96M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 11.32K | n/a | $2.34M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 3.76K | n/a | $775,914 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 2.75K | n/a | $568,095 | 0.0% | n/c | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 555 持有人, 56.84M 股份, $9.32B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Sep 30
Coleman Glenn
Officer · EVP & Chief Financial… · 10 股 @ 297.43 · $2,974
公开市场卖出 (S)
Oct 05
Parisotto Shannon M
Officer · 981 股 · $302,580
Aug 25
FOSTER JAMES C
Director · 33.56K 股 · $10.07M
Aug 19
Parisotto Shannon M
Officer · 2.04K 股 · $599,711
Aug 18
Andrews Nancy C
Director · 573 股 · $163,443
Aug 11
Girshick Birgit
Officer, Director · 6.50K 股 · $1.82M
Aug 11
Parisotto Shannon M
Officer · 3.71K 股 · $1.04M
Aug 10
FOSTER JAMES C
Director · 28.73K 股 · $7.90M
Aug 06
Knell Michael Gunnar
Officer · 620 股 · $163,643
Aug 06
Knell Michael Gunnar
Officer · 482 股 · $127,812
Aug 06
Knell Michael Gunnar
Officer · 404 股 · $104,446
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Sep 08
SC 13G/A: FMR LLC
Aug 13
SC 13G: Invesco Ltd.
Aug 06
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据